Technology

Onconova Therapeutics

$0.7054
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0248 (-3.49%) Today
+$0.0202 (+2.95%) As of 1:10 PM UTC after-hours

Why Robinhood?

You can buy or sell ONTX and other stocks, options, and ETFs commission-free!

About ONTX

Onconova Therapeutics, Inc. Common Stock, also called Onconova Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA. The listed name for ONTX is Onconova Therapeutics, Inc. Common Stock.

CEO
Steven M. Fruchtman
Employees
19
Headquarters
Newtown, Pennsylvania
Founded
1998
Market Cap
149.73M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
31.89M
High Today
$0.74
Low Today
$0.681
Open Price
$0.7303
Volume
19.65M
52 Week High
$1.56
52 Week Low
$0.1901

Collections

ONTX Earnings

-$0.82
-$0.55
-$0.27
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 23, After Hours

You May Also Like

RVRS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure